Go to
JCI Insight
Citations to this article
Alan N. Houghton, José A. Guevara-Patiño
Published August 16, 2004
Citation Information: J Clin Invest. 2004;114(4):468-471. https://doi.org/10.1172/JCI22685.
Citation Information: J Clin Invest. 2004;114(4):468-471. https://doi.org/10.1172/JCI22685.
Abstract
Most antigens expressed by human cancer cells and recognized by host T cells and antibodies are nonmutated self antigens — molecules also expressed on the surface of normal cells. These self antigens are ineffective at triggering immune responses against cancer cells, which provides one explanation for the difficulties in trying to immunize against human cancer. A new study describes how tumors can avoid recognition by the immune system and how enhancing the affinity of the interaction between a self antigen and the MHC-I molecule may lead to cancer immunity.
Authors
Alan N. Houghton, José A. Guevara-Patiño
Total citations by year
Citation information
Citations to this article (63)
| Title and authors | Publication | Year |
|---|---|---|
|
Immune Cytolytic Activity and Strategies for Therapeutic Treatment
Agioti S, Zaravinos A |
International journal of molecular sciences | 2024 |
|
Exhausted T cells hijacking the cancer-immunity cycle: Assets and liabilities
Brunell AE, Lahesmaa R, Autio A, Thotakura AK |
Frontiers in immunology | 2023 |
|
Identifying cancer-associated leukocyte profiles using high-resolution flow cytometry screening and machine learning.
Simon Davis DA, Ritchie M, Hammill D, Garrett J, Slater RO, Otoo N, Orlov A, Gosling K, Price J, Yip D, Jung K, Syed FM, Atmosukarto II, Quah BJC |
Frontiers in immunology | 2023 |
|
Boosting the Immune Response—Combining Local and Immune Therapy for Prostate Cancer Treatment
Karwacki J, Kiełbik A, Szlasa W, Sauer N, Kowalczyk K, Krajewski W, Saczko J, Kulbacka J, Szydełko T, Małkiewicz B |
Cells | 2022 |
|
Metalloimmunotherapy with Rhodium and Ruthenium Complexes: Targeting Tumor-Associated Macrophages
Toupin N, Herroon MK, Thummel RP, Turro C, Podgorski I, Gibson H, Kodanko JJ |
Chemistry (Weinheim an der Bergstrasse, Germany) | 2022 |
|
Importance of Extracellular Vesicle Derived RNAs as Critical Colorectal Cancer Biomarkers.
Datta B, Paul D, Dey T, Pal S, Rakshit T |
2022 | |
|
A novel monoclonal antibody associated with glucoside kills gastric adenocarcinoma AGS cells based on glycosylation target.
Xu H, Dun B, Liu B, Mysona D, She JX, Ma R |
Journal of Cellular and Molecular Medicine | 2022 |
|
CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma.
Chan CY, Chiu DK, Yuen VW, Law CT, Wong BP, Thu KL, Cescon DW, Soria-Bretones I, Cheu JW, Lee D, Tse AP, Zhang MS, Tan KV, Ng IO, Khong PL, Yau TC, Bray MR, Mak TW, Wong CC |
Proceedings of the National Academy of Sciences | 2022 |
|
Inflammation-based Indexes Upon Adjuvant Chemotherapy Initiation as a Predictor of Relapse After Curative Resection of Colorectal Cancer With an Oxaliplatin-based Regimen.
Satake M, Yoshimatsu K, Sagawa M, Yokomizo H, Shiozawa S |
2022 | |
|
Helicobacter pylori and gastric cancer: a lysosomal protease perspective
SM Soond, AA Zamyatnin |
Gastric Cancer | 2021 |
|
Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment
Y Huang, HC Wang, J Zhao, MH Wu, TC Shih |
Biomolecules | 2021 |
|
Double-edged effects of interferons on the regulation of cancer-immunity cycle
X Zhang, S Wang, Y Zhu, M Zhang, Y Zhao, Z Yan, Q Wang, X Li |
OncoImmunology | 2021 |
|
The Evolution of Cancer Immunotherapy.
Khan M, Maker AV, Jain S |
Human vaccines | 2021 |
|
Nanoparticle-enabled innate immune stimulation activates endogenous tumor-infiltrating T cells with broad antigen specificities.
Yin Q, Yu W, Grzeskowiak CL, Li J, Huang H, Guo J, Chen L, Wang F, Zhao F, von Boehmer L, Metzner TJ, Leppert JT, Chien YH, Kuo CJ, Davis MM |
Proceedings of the National Academy of Sciences | 2021 |
|
APOBEC and Cancer Viroimmunotherapy: Thinking the Unthinkable.
Vile RG, Melcher A, Pandha H, Harrington KJ, Pulido JS |
Clinical cancer research | 2021 |
|
Organized immune cell interactions within tumors sustain a productive T-cell response
MA Cardenas, N Prokhnevska, HT Kissick |
International Immunology | 2020 |
|
The Crosstalk between Microbiome and Immune Response in Gastric Cancer
R Nasr, A Shamseddine, D Mukherji, F Nassar, S Temraz |
International journal of molecular sciences | 2020 |
|
Tumor immune response and immunotherapy in gastric cancer
Y Kwak, AN Seo, HE Lee, HS Lee |
Journal of Pathology and Translational Medcine | 2020 |
|
HNSCC: Tumour Antigens and Their Targeting by Immunotherapy
A von Witzleben, C Wang, S Laban, N Savelyeva, CH Ottensmeier |
Cells | 2020 |
|
In Vitro Studies Toward the Use of Chitin as Nutraceutical: Impact on the Intestinal Epithelium, Macrophages, and Microbiota.
Dong L, Ariëns RMC, Tomassen MM, Wichers HJ, Govers C |
Molecular Nutrition & Food Research | 2020 |
|
Differential prognostic impact of CD8(+) T cells based on human leucocyte antigen I and PD-L1 expression in microsatellite-unstable gastric cancer.
Kwak Y, Koh J, Park Y, Hong YJ, Park KU, Kim HH, Park DJ, Ahn SH, Kim WH, Lee HS |
British Journal of Cancer | 2020 |
|
＜Editors' Choice＞ Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunity
Vitaly Kochin, Hiroyoshi Nishikawa |
NAGOYA J MED SCI | 2019 |
|
Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity
Scott R. Walsh, Donald Bastin, Lan Chen, Andrew Nguyen, Christopher J. Storbeck, Charles Lefebvre, David Stojdl, Jonathan L. Bramson, John C. Bell, Yonghong Wan |
Journal of Clinical Investigation | 2018 |
|
Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)
YK Chae, A Arya, W Iams, MR Cruz, S Chandra, J Choi, F Giles |
Journal for ImmunoTherapy of Cancer | 2018 |
|
Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity
CY Chiang, YJ Chen, CC Wu, SJ Liu, CH Leng, HW Chen |
Frontiers in immunology | 2018 |
|
Thrombospondins and remodeling of the tumor microenvironment.
Stenina-Adognravi O, Muppala S, Gajeton J |
Vessel plus | 2018 |
|
Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme.
Chin C, Lunking ES, de la Fuente M, Ayad NG |
Frontiers in Oncology | 2018 |
|
Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis
Wen YH, Lin HQ, Li H, Zhao Y, Lui VW, Chen L, Wu XM, Sun W, Wen WP |
Cancer Immunology, Immunotherapy | 2018 |
|
Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes.
Pilli T, Toti P, Occhini R, Castagna MG, Cantara S, Caselli M, Cardinale S, Barbagli L, Pacini F |
Journal of Endocrinological Investigation | 2017 |
|
The Antibody Repertoire of Colorectal Cancer.
Cha SW, Bonissone S, Na S, Pevzner PA, Bafna V |
Molecular & cellular proteomics : MCP | 2017 |
|
Enhancement of antitumor immunity by combination of anti-CTLA-4 antibody and radioimmunotherapy through the suppression of Tregs.
Son CH, Bae J, Lee HR, Yang K, Park YS |
Oncology Letters | 2017 |
|
Effector, Memory, and Dysfunctional CD8 + T Cell Fates in the Antitumor Immune Response
J Reiser, A Banerjee |
Journal of Immunology Research | 2016 |
|
pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens.
Hundal J, Carreno BM, Petti AA, Linette GP, Griffith OL, Mardis ER, Griffith M |
Genome Medicine | 2016 |
|
T Cells Integrate Local and Global Cues to Discriminate between Structurally Similar Antigens.
Voisinne G, Nixon BG, Melbinger A, Gasteiger G, Vergassola M, Altan-Bonnet G |
Cell Reports | 2015 |
|
A Listeria Vaccine and Depletion of T-Regulatory Cells Activate Immunity Against Early Stage Pancreatic Intraepithelial Neoplasms and Prolong Survival of Mice
BP Keenan, Y Saenger, MI Kafrouni, A Leubner, P Lauer, A Maitra, AA Rucki, AJ Gunderson, LM Coussens, DG Brockstedt, TW Dubensky, R Hassan, TD Armstrong, EM Jaffee |
Gastroenterology | 2014 |
|
What is Recent in Pancreatic Cancer Immunotherapy?
E Niccolai, D Prisco, MM D'Elios, A Amedei |
BioMed Research International | 2013 |
|
Carbon nanotubes as vaccine scaffolds
DA Scheinberg, MR McDevitt, T Dao, JJ Mulvey, E Feinberg, S Alidori |
Advanced Drug Delivery Reviews | 2013 |
|
Tumor-Associated Glycans and Immune Surveillance
B Monzavi-Karbassi, A Pashov, T Kieber-Emmons |
Human vaccines | 2013 |
|
Prospective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial.
Issa-Nummer Y, Darb-Esfahani S, Loibl S, Kunz G, Nekljudova V, Schrader I, Sinn BV, Ulmer HU, Kronenwett R, Just M, Kühn T, Diebold K, Untch M, Holms F, Blohmer JU, Habeck JO, Dietel M, Overkamp F, Krabisch P, von Minckwitz G, Denkert C |
PloS one | 2013 |
|
Targeting the intracellular WT1 oncogene product with a therapeutic human antibody.
Dao T, Yan S, Veomett N, Pankov D, Zhou L, Korontsvit T, Scott A, Whitten J, Maslak P, Casey E, Tan T, Liu H, Zakhaleva V, Curcio M, Doubrovina E, O'Reilly RJ, Liu C, Scheinberg DA |
Science Translational Medicine | 2013 |
|
Potential targets for pancreatic cancer immunotherapeutics
LF Dodson, WG Hawkins, P Goedegebuure |
Immunotherapy | 2011 |
|
Development of Tumor-Infiltrating CD8 + T Cell Memory Precursor Effector Cells and Antimelanoma Memory Responses Are the Result of Vaccination and TGF-β Blockade during the Perioperative Period of Tumor Resection
EC Bellavance, FJ Kohlhapp, A Zloza, JA OSullivan, J McCracken, MC Jagoda, AT Lacek, MC Posner, JA Guevara-Patino |
Journal of immunology (Baltimore, Md. : 1950) | 2011 |
|
TRAIL/DR5 Plays a Critical Role in NK Cell-Mediated Negative Regulation of Dendritic Cell Cross-Priming of T Cells
M Iyori, T Zhang, H Pantel, BA Gagne, CL Sentman |
Journal of immunology (Baltimore, Md. : 1950) | 2011 |
|
Conceptual aspects of self and nonself discrimination.
Gonzalez S, González-Rodríguez AP, Suárez-Álvarez B, López-Soto A, Huergo-Zapico L, Lopez-Larrea C |
Self/Nonself | 2011 |
|
Single-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigens.
Villa CH, Dao T, Ahearn I, Fehrenbacher N, Casey E, Rey DA, Korontsvit T, Zakhaleva V, Batt CA, Philips MR, Scheinberg DA |
ACS Nano | 2011 |
|
Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens
L Li, JM Herndon, SM Truscott, TH Hansen, TP Fleming, P Goedegebuure, WE Gillanders |
Vaccine | 2010 |
|
Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression
TL Whiteside |
Expert Opinion on Biological Therapy | 2010 |
|
The roles of antigen-specificity, responsiveness to transforming growth factor-β and antigen-presenting cell subsets in tumour-induced expansion of regulatory T cells
D Coe, C Addey, M White, E Simpson, J Dyson, JG Chai |
Immunology | 2010 |
|
Basic and translational applications of engineered MHC class I proteins.
Hansen TH, Connolly JM, Gould KG, Fremont DH |
Trends in Immunology | 2010 |
|
TAA polyepitope DNA-based vaccines: a potential tool for cancer therapy.
Bei R, Scardino A |
Journal of biomedicine & biotechnology | 2010 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
|
Targeting the Intratumoral Dendritic Cells by the Oncolytic Adenoviral Vaccine Expressing RANTES Elicits Potent Antitumor Immunity:
N Lapteva, M Aldrich, D Weksberg, L Rollins, T Goltsova, SY Chen, XF Huang |
Journal of immunotherapy (Hagerstown, Md. : 1997) | 2009 |
|
Mechanisms of Immunization Against Cancer Using Chimeric Antigens
ME Engelhorn, JA Guevara-Patiño, T Merghoub, C Liu, CR Ferrone, GA Rizzuto, DH Cymerman, DN Posnett, AN Houghton, JD Wolchok |
Molecular Therapy | 2008 |
|
Immunisation with 'naïve' syngeneic dendritic cells protects mice from tumour challenge
MJ Grimshaw, K Papazisis, G Picco, H Bohnenkamp, T Noll, J Taylor-Papadimitriou, J Burchell |
British Journal of Cancer | 2008 |
|
Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy
VM Velazquez, DG Bowen, CM Walker |
Blood | 2008 |
|
Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity
Preise D, Oren R, Glinert I, Kalchenko V, Jung S, Scherz A, Salomon Y |
Cancer Immunology, Immunotherapy | 2008 |
|
Resistance to apoptosis and expansion of regulatory T cells in relation to the detection of circulating tumor cells in patients with metastatic epithelial cancer.
Stanzer S, Dandachi N, Balic M, Resel M, Samonigg H, Bauernhofer T |
Journal of Clinical Immunology | 2007 |
|
Recognition of self-peptide-MHC complexes by autoimmune T-cell receptors.
Deng L, Mariuzza RA |
Trends in Biochemical Sciences | 2007 |
|
TCR recognition of peptide/MHC class II complexes and superantigens.
Sundberg EJ, Deng L, Mariuzza RA |
Seminars in Immunology | 2007 |
|
Optimization of a self-antigen for presentation of multiple epitopes in cancer immunity
José A. Guevara-Patiño, Manuel E. Engelhorn, Mary Jo Turk, Cailian Liu, Fei Duan, Gabrielle Rizzuto, Adam D. Cohen, Taha Merghoub, Jedd D. Wolchok, and Alan N. Houghton |
Journal of Clinical Investigation | 2006 |
|
Agonist Anti-GITR Antibody Enhances Vaccine-Induced CD8 + T-Cell Responses and Tumor Immunity
AD Cohen, A Diab, MA Perales, JD Wolchok, G Rizzuto, T Merghoub, D Huggins, C Liu, MJ Turk, NP Restifo, S Sakaguchi, AN Houghton |
Cancer research | 2006 |
|
Order, disorder, death: lessons from a superorganism.
Amdam GV, Seehuus SC |
Advances in cancer research | 2006 |
|
Chronic Lymphocytic Leukemia Cells Induce Changes in Gene Expression of CD4 and CD8 T Cells
Güllü Görgün, Tobias AW Holderried, David Zahrieh, Donna Neuberg and John G Gribben. |
Journal of Clinical Investigation | 2005 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)